Collaborations to Enhance Drug Development and Regulatory Science

Q: When is the deadline for Collaborations to Enhance Drug Development and Regulatory Science?

This is a forecast opportunity; the agency has not posted dates yet.

Q: Who is eligible for Collaborations to Enhance Drug Development and Regulatory Science?

Eligible applicants: Open to all applicant types.

Food and Drug Administration

Federal Grants for Science Research

Funding Amount

$5,000,000 - $5,000,000

Deadline

Forecast — dates not yet posted

Number of Awards

Grant Type

Federal

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Open to all applicant types

Overview

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.